Therapeutic Drug Monitoring Market Size And Global Industry Forecast
                     Drug Screening Market
Global Forecast to 2029
Drug Screening Market
is expected to reach
$19.5 Billion 
by 2029
Growing at a
  CAGR of 16.6% (2024 – 2029)
Request Sample
DRUG SCREENING MARKET WORTH $19.5 
BILLION BY 2029
MARKET 
CAGR of 16.8 TWO OF THE KEY OPPORTUNITY  KEY MARKET 
2024 – DRIVERS OF  THE OVER NEXT 5 PLAYERS
2029 6  MARKET WILL BE:YEARS 19.5 Abbott Laboratories (US)Bn
CAGR 4   Thermo Fisher Scientific  Growing drug and9.1 Bn (US) alcohol consumption
2  Quest Diagnostics (US)
0
2024 2029
North America to dominate the MARKET 
drug  screening market SEGMENTATION
BY EQUIPMENT 
 ServiCcAesT EsGegOmRYe:nt is 
expected  to grow at the 
highest CAGR  during the 
The rising drug & alcohol  forecast period
consumption, the 

enforcement of  stringent laws Based on the sample 
mandating drug and  alcohol type, the  urine sample segment is  accounted for 
testing, government funding  the largest share  of the 
in major markets, and drug screening market.
regulatory  approvals and 
product and service  launches 
are the major factors  driving 
the growth of this market.
Drug Screening Market worth $19.5 billion by 
 2029
The report "Drug Screening Market by Product (Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, 
Chromatography)),  Sample (Urine, Breath, Hair), Drug (Alcohol, Cannabis, Opioids), End User (Workplace, Hospital, Law) - Global 
Forecast to 2029", is  projected to reach USD 19.5 billion by 2029, from USD 9.1 billion in 2024, at a CAGR of 16.6%. Factors 
such as mounting drug & alcohol  consumption, enforcement of stringent laws mandating drug and alcohol testing, increasing 
government funding in major markets, and rising  regulatory approvals and service and product launches are the some of the 
factors driving the growth of this market.
Browse 740 market data Tables and 62 Figures spread through 504 Pages and in-depth TOC on "Drug Screening Market by Product 
 (Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)), Sample (Urine, Breath, Hair), Drug (Alcohol, 
 Cannabis, Opioids), End User (Workplace, Hospital, Law) - Global Forecast to 2029"
Drug Screening Market worth $19.5 billion by 
 2029
Services segment is expected to grow at the highest CAGR during the forecast period.
Based on service and product, the drug screening market is segmented into services and products. The services segment 
account ed for the  largest share of 57.4% of the drug screening market . This segment is also expected to register the highest 
CAGR during the forecast period,  mainly due to the growing drug & alcohol consumption worldwide, funding initiatives for 
drug testing laboratories, service launches and regulatory  approvals, and geographic expansion of drug testing laboratories.
Analytical instruments are expected to dominate the drug screening products market .
Based on the product, the drug screening market is segmented into analytical instruments, rapid testing devices, and 
consumables. the analytical  segment is expected to dominate the market with a share of 53.0%. The high growth in this 
segment is owing to their recurring requirement and  repetitive usage.
Drug Screening Market worth $19.5 billion by 
 2029
Based on the sample type, the urine sample segment is accounted for the largest share of the drug screening market.
By sample type, drug screening market is segmented into urine, breath, oral fluid, hair, and other samples. Among these, the 
urine sample  segment is expected to account for the largest share of 61.5% . The high growth of this segment is attributed 
due to the benefits it offers such as  easy collection method, high accuracy in the detection of multiple drugs, cost-
effectiveness, and instant results.
North America to dominate the drug screening market .
In 2020, North America is expected to dominate the market with a share of 48.2%, followed by Europe. The large share of this 
geographical  segment is attributed to factors such as growing consumption of illicit drugs, the availability of government 
funding to curb drug abuse, laws  supporting drug screening, the growing burden of accidents due to alcohol impairment, and 
the presence of key players in the region are driving  the growth of the drug screening market in this region.
Drug Screening Market worth $19.5 billion by 
 2029
The drug screening market is highly competitive with the presence of several small and big players. Some of the players 
offer ing products for  drug screening market include Abbott Laboratories (US), Thermo Fisher Scientific (US), Quest 
Diagnostics (US), Alfa Scientific Designs (US),  Roche (Switzerland), OraSure Technologies (US), MPD Inc. (US), and 
Shimadzu (Japan).
Don’t miss out on business opportunities in Drug Screening Market. Speak to our analyst and gain crucial industry insights that 
will
help your business grow.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will 
impact 70% to 80% of  worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of 
global Fortune 1000 companies as  clients. Almost 75,000 top officers across eight industries worldwide approach 
MarketsandMarkets™ for their painpoints around revenues  decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the 
"Growth Engagement  Model – GEM". The GEM aims at proactive collaboration with the clients to identify new 
opportunities, identify most important customers,  write "Attack, avoid and defend" strategies, identify sources of 
incremental revenues for both the company and its competitors.
MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging 
companies,  innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is 
determined to benefit more than 10,000  companies this year for their revenue planning and help them take their 
innovations/disruptions early to the market by providing them  research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 
200,000 markets
and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche 
markets.
Contact:
Mr. Aashish Mehra  
MarketsandMarkets™ 
INC.  630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmark
ets.com